Energy News / Shareholders Foundation, Inc.

NASDAQ:CORT Long-Term Shareholder Notice: Investigation of Potential Wrongdoing at Corcept Therapeutics Incorporated

Via: ReleaseWire

Updated 11:15 AM CDT, Mon, June 17,2019

An investigation on behalf of current long term investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ: CORT stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 06/17/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Corcept Therapeutics Incorporated.

Investors who are current long-term investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long-term investors in NASDAQ: CORT stocks follows a lawsuit filed against Corcept Therapeutics over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CORT stocks, concerns whether certain Corcept Therapeutics Incorporated directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the defendants failed to disclose to investors that the Company had improperly paid doctors to promote its drug Korlym, that the Company aggressively promoted Korlym for off-label uses, that the Company's sole specialty pharmacy was a related party, that the Company artificially inflated its revenue and sales using illicit sales practices through a related party, that such practices are reasonably likely to lead to regulatory scrutiny, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqcort-long-term-shareholder-notice-investigation-of-potential-wrongdoing-at-corcept-therapeutics-incorporated-1233798.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com